For a list of recent publications, please see Stephen Fowler’s Google Scholar page:

Selected Publications


Fowler SJ. Breath analysis for label-free characterisation of airways disease. 

Lawal O, Muhamadali H, Ahmed WM, et al. Headspace volatile organic compounds from bacteria implicated in ventilator-associated pneumonia analysed by TD-GC/MS. Journal of Breath Research. 2018


Ahmed WM, Lawal O, Nijsen TM, et al. Exhaled Volatile Organic Compounds of Infection: A Systematic ReviewACS Infectious Diseases. 2017: 10.1021/acsinfecdis.7b00088

Lawal O, Ahmed WM, Nijsen TME, et al. Exhaled breath analysis: a review of ‘breath-taking’ methods for off-line analysisMetabolomics. 2017; 13:110

Horváth I, Barnes P, Högman M, et al. A European Respiratory Society technical standard: exhaled biomarkers in lung disease. Eur Respir J. 2017; 49

van Oort PMP, Nijsen T, Weda H, et al. BreathDx – molecular analysis of exhaled breath as a diagnostic test for ventilator–associated pneumonia: protocol for a European multicentre observational study. BMC Pulm. Med. 2017; 17: 1


Bos LD, Sterk PJ, Fowler SJ. Breathomics in the setting of asthma and chronic obstructive pulmonary disease. J. Allergy Clin. Immunol.; 2016; 138: 970–976


Fleming L, Murray C, Bansal AT, et al, The burden of severe asthma in childhood and adolescence: Results from the paediatric U-BIOPRED cohorts. Eur. Respir. J. 2015; 46: 1322–1333

Fowler SJ, Basanta-Sanchez M, Xu Y, et al. Surveillance for lower airway pathogens in mechanically ventilated patients by metabolomic analysis of exhaled breath: a case-control study. Thorax. 2015; 70: 320–325


Rattray NJW, Hamrang Z, Trivedi DK, et al. Taking your breath away: metabolomics breathes life in to personalized medicine. Trends Biotechnol. 2014; 32: 538–548


Ibrahim B, Marsden P, Smith JA, et alBreath metabolomic profiling by nuclear magnetic resonance spectroscopy in asthma. Allergy 2013; 68: 1050–1056

Fowler SJ, Yun X, Maria B, et al. Breath Analysis On The Intensive Care Unit: Screening Invasively Ventilated Patients For Lower Respiratory Tract Pathogens. Am. J. Respir. Crit. Care Med. 2013; : A1322–A1322

Xu Y, Fowler SJ, Bayat A, et alChemometrics models for overcoming high between subject variability: applications in clinical metabolic profiling studies. Metabolomics 2013; 10: 375–385

2012 and older

Basanta M, Ibrahim B, Dockry R, et al. Exhaled volatile organic compounds for phenotyping chronic obstructive pulmonary disease: a cross-sectional study. Respir. Res. 2012; 13: 72

Basanta M, Ibrahim B, Douce D, et alMethodology validation, intra-subject reproducibility and stability of exhaled volatile organic compounds. J. Breath Res. 2012; 6: 26002